Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10259765 | 0.99 | ENPP3 (0.41) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10267352 | 0.94 | CA12 (0.41) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10259819 | 0.93 | PIM1 (0.40) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10260202 | 0.93 | PIM1 (0.40) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10260212 | 0.93 | PIM1 (0.40) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL15334682 | 0.92 | PIM1 (0.39) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10260776 | 0.91 | CA12 (0.40) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10259759 | 0.87 | PIM1 (0.36) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL15334680 | 0.86 | ABCG2 (0.39) | CA12CA1CA2CA9ENPP3 | |
| SCHEMBL10259962 | 0.85 | PIM1 (0.40) | CYP2C19ALDH1A1HSD17B10CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563972-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-22 | — | — | US | disclosed |
| US-8563972-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-22 | — | — | US | disclosed |
| US-20130248838-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248838-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-8471251-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-8471251-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-20 | — | — | US | disclosed |
| US-8324619-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| US-8324619-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-09-13 | — | — | US | disclosed |
| US-8212239-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-8212239-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-02-24 | — | — | US | disclosed |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.